Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole

Código QR

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole

Subramanian Madhusoodanan1, Payal Shah21St John’s Episcopal Hospital Far Rockaway, NY 11691, SUNY, Brooklyn NY, USA. 2SUNY Health Science Center, Brooklyn, NYAbstract: Psychosis of Alzheimer’s disease (AD) is characterized by delusions or hallucinations and may be associated with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Subramanian Madhusoodanan, Payal Shah
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Treatment Alzheimer’s Dementia Psychosis Aripiprazole Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/59c72234c0a0492db3db2960ee8d3a50
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010)

Aripiprazole for late-life schizophrenia
por: Jeffrey Rado, et al.
Publicado: (2010)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
por: Fowler NR, et al.
Publicado: (2018)

Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
por: Adams CD
Publicado: (2020)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Noll Campbell, et al.
Publicado: (2008)

PSEN1 L226F mutation in a patient with early-onset Alzheimer’s disease in Korea
por: Bagyinszky E, et al.
Publicado: (2016)

Cognitive fluctuations in connection to dysgraphia: a comparison of Alzheimer’s disease with dementia Lewy bodies
por: Onofri E, et al.
Publicado: (2015)

Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
por: Millán-Calenti JC, et al.
Publicado: (2016)

Evaluation of a computer-assisted errorless learning-based memory training program for patients with early Alzheimer’s disease in Hong Kong: a pilot study
por: Lee GY, et al.
Publicado: (2013)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Prevalence of dementia in Al-Quseir city, Red Sea Governorate, Egypt
por: El Tallawy HN, et al.
Publicado: (2013)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
por: Bektaş O, et al.
Publicado: (2015)

Laypersons’ Priority-Setting Preferences for Allocating a COVID-19 Patient to a Ventilator: Does a Diagnosis of Alzheimer’s Disease Matter?
por: Werner P, et al.
Publicado: (2020)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

A case of possibly pathogenic PSEN2 R62C mutation in a patient with probable early-onset Alzheimer’s dementia supported by structure prediction
por: Park KW, et al.
Publicado: (2017)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

Public–private partnerships improve health outcomes in individuals with early stage Alzheimer’s disease
por: Galvin JE, et al.
Publicado: (2014)

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
por: Yatawara C, et al.
Publicado: (2021)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
por: Li XH, et al.
Publicado: (2015)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai Y, et al.
Publicado: (2015)

Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials
por: Gauthier S, et al.
Publicado: (2014)

Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease
por: Gregory A Jicha, et al.
Publicado: (2010)

Gene Set Index Based on Different Modules May Help Differentiate the Mechanisms of Alzheimer’s Disease and Vascular Dementia
por: Zhou F, et al.
Publicado: (2021)

Rehabilitating a brain with Alzheimer's: a proposal
por: Gonzalo Emiliano Aranda-Abreu, et al.
Publicado: (2011)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
por: Wu P, et al.
Publicado: (2015)

Cerebral small vessel disease and Alzheimer’s disease
por: Cai Z, et al.
Publicado: (2015)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
por: Jelcic N, et al.
Publicado: (2014)

Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
por: Cardoso BR, et al.
Publicado: (2013)

Use of atypical antipsychotics in the elderly: a clinical review
por: Gareri P, et al.
Publicado: (2014)

Spaced Retrieval and Episodic Memory Training in Alzheimer’s Disease
por: Small JA, et al.
Publicado: (2020)

Vitamin E and Alzheimer’s disease: what do we know so far?
por: Browne D, et al.
Publicado: (2019)

General anesthetic and the risk of dementia in elderly patients: current insights
por: Hussain M, et al.
Publicado: (2014)

RAB10: an Alzheimer’s disease resilience locus and potential drug target
por: Tavana JP, et al.
Publicado: (2018)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

Pain management in patients with dementia
por: Achterberg WP, et al.
Publicado: (2013)

Altered diastolic function and aortic stiffness in Alzheimer’s disease
por: Çalık AN, et al.
Publicado: (2014)